Literature DB >> 34051818

The cancer-associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer.

YiHeng Du1, Xiang Jiang2, Bo Wang1, Jin Cao2, Yi Wang1, Jiang Yu1, XiZhi Wang1, HaiTao Liu3.   

Abstract

BACKGROUND: Stromal components of the tumor microenvironment contribute to bladder cancer progression, and Cancer-Associated Fibroblasts (CAFs) were reported to play an important role. Accumulating pieces of evidence indicate that CAFs participate in the crosstalk with tumor cells and have a complex interaction network with immune components. Further studies on the role of CAFs in the bladder cancer microenvironment and searching for possible specific markers are important for a deeper understanding of CAFs in bladder cancer progression and immunomodulation.
METHODS: In the present study, we examined the abundance of CAFs in the TCGA and GEO datasets using the MCP-COUNTER algorithm. Additionally, the expression of genes related to CAFs was analyzed through the Weighted Gene Co-expression Network Analysis (WGCNA). The CIBERSORT and ESTIMATE algorithms were used to discuss the correlation of the key CAFs-related gene and the tumor microenvironment components. Immunohistochemistry analysis in clinical samples was used to validate the results of bioinformatics analysis.
RESULTS: The results showed that CAFs were closely associated with the progression and prognosis of bladder cancer. WGCNA also revealed that CALD1 was a key CAFs-related gene in bladder cancer. Moreover, further in-depth analysis showed that CALD1 significantly affected the progression and prognosis of bladder cancer. The CIBERSORT and ESTIMATE algorithms demonstrated significant correlations between CALD1 and the tumor microenvironment components, including CAFs, macrophages, T cells, and multiple immune checkpoint related genes. Finally, immunohistochemistry results validated the strong association of CALD1 with CAFs and macrophages.
CONCLUSIONS: In the present study, we confirmed the cancer-promoting roles of CAFs in bladder cancer. Being a key gene associated with CAFs, CALD1 may promote bladder cancer progression by remodeling the tumor microenvironment. The bioinformatics methods, including the CIBERSORT, MCP-COUNTER and ESTIMATE algorithms, may provide important value for studying the tumor microenvironment.

Entities:  

Keywords:  Bladder cancer; CALD1; Cancer‐associated fibroblasts; Immunosuppression; Prognostic biomarker

Year:  2021        PMID: 34051818     DOI: 10.1186/s12935-021-01896-x

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  2 in total

Review 1.  Bladder cancer.

Authors:  Ashish M Kamat; Noah M Hahn; Jason A Efstathiou; Seth P Lerner; Per-Uno Malmström; Woonyoung Choi; Charles C Guo; Yair Lotan; Wassim Kassouf
Journal:  Lancet       Date:  2016-06-23       Impact factor: 79.321

2.  Macrophages activate mesenchymal stem cells to acquire cancer-associated fibroblast-like features resulting in gastric epithelial cell lesions and malignant transformation in vitro.

Authors:  Qiang Zhang; Shuo Chai; Wei Wang; Chengcheng Wan; Feng Zhang; Yuyun Li; Fengchao Wang
Journal:  Oncol Lett       Date:  2018-11-15       Impact factor: 2.967

  2 in total
  6 in total

1.  Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma.

Authors:  Clare A Rebbeck; Jian Xian; Susanne Bornelöv; Joseph Geradts; Amy Hobeika; Heather Geiger; Jose Franco Alvarez; Elena Rozhkova; Ashley Nicholls; Nicolas Robine; Herbert K Lyerly; Gregory J Hannon
Journal:  Nat Commun       Date:  2022-06-13       Impact factor: 17.694

2.  MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing.

Authors:  Sheng Zhang; Qin Wang; Wenfeng Li; Jinzhong Chen
Journal:  Front Mol Biosci       Date:  2022-01-21

3.  KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study.

Authors:  Fei Sun; Yingying Lian; Jianlin Wang; Lijun Hu; Judong Luo; Jingping Yu
Journal:  J Oncol       Date:  2022-03-22       Impact factor: 4.375

Review 4.  Immune status for monitoring and treatment of bladder cancer.

Authors:  Shen Pan; Shijie Li; Yunhong Zhan; Xiaonan Chen; Ming Sun; Xuefeng Liu; Bin Wu; Zhenhua Li; Bitian Liu
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 5.  Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers.

Authors:  Alya R Alnuaimi; Vidhya A Nair; Lara J Bou Malhab; Eman Abu-Gharbieh; Anu Vinod Ranade; Gianfranco Pintus; Mohamad Hamad; Hauke Busch; Jutta Kirfel; Rifat Hamoudi; Wael M Abdel-Rahman
Journal:  World J Gastrointest Oncol       Date:  2022-09-15

6.  CMTM3 as a Potential New Immune Checkpoint Regulator.

Authors:  Qian Shen; Zhirong Cong; Ying Zhou; Yue Teng; Jin Gao; Weiyan Tang
Journal:  J Oncol       Date:  2022-09-20       Impact factor: 4.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.